COVID-19 Site Update

OPEN AND OPERATIONAL WITH SAFETY PRECAUTIONS

Cedar Crosse Research Center would like to take this opportunity to inform our patients and sponsors how COVID-19 is affecting our research site. We are gathering as much information as possible to ensure that we can set feasible expectations, maintain infectious disease precautions for the safety of our patients and site staff, and preserve the integrity of the clinical trial data for our sponsors.

Our site staff has enacted extraordinary measures within our facility to reduce the potential contamination of not only the COVID-19 virus but also any other contaminant that may affect our staff or patients. Safety policy staff trainings have occurred weekly and sanitizing stations have been installed throughout our facility. Listed below are additional site updates:

 – We have not made any decisions to initiate office closure, reduce staffing, and change receipt or shipment of study supplies (IP, lab kits, etc.) regarding research operations due to COVID-19.

 – We are communicating with our enrolled patients via email, telephone and text and are addressing their concerns. We are still conducting patient office visits as deemed necessary by Principal Investigator. All study patients have received a site newsletter via email or mail regarding our COVID-19 safety and operation policies for their respective clinical trials.

 – We are very concerned for our monitors and we will do everything within our means to assist them during this precarious time. To reduce possible person to person cross contamination, we would like to request that our sponsors provide remote monitoring visits if possible.